Anal Stretch — Cost, Top Hospitals & Success Rates | MyMedicPlus

Anal stretch, also known as anal dilatation or Lord's procedure, is a surgical technique historically used to treat chronic anal fissure and anal stenosis by manually dilating the anal sphincter under general or regional anaesthesia. The procedure involves the controlled stretching of the internal anal sphincter, the involuntary muscular ring at the anal canal, with the goal of reducing pathologically elevated resting anal pressure that perpetuates the cycle of fissure pain, spasm, and ischaemia.

First described by Peter Lord in 1969, the procedure involves inserting four or more fingers into the anal canal under anaesthesia to stretch the sphincter mechanism. The rationale is identical to that of lateral internal sphincterotomy (LIS) — reducing internal anal sphincter (IAS) hypertonia to restore blood flow to the posterior midline commissure and allow fissure healing. However, anal stretch as traditionally described has fallen significantly out of favour compared to LIS due to a substantially higher rate of faecal incontinence resulting from uncontrolled sphincter tearing.

Modern practice has largely replaced classic four-finger anal dilatation with more controlled alternatives, including anal advancement flaps, botulinum toxin injection, and lateral internal sphincterotomy. Limited or controlled anal dilatation using calibrated dilators (pneumatic balloon dilatation) remains in use for anal stenosis following surgery or inflammatory conditions, where the goal is to progressively widen a strictured anal canal rather than to treat fissure.

Chronic anal fissure — a longitudinal tear in the anoderm usually at the posterior midline — is the primary indication for which anal stretch was historically performed. Chronic fissures persist beyond 6–8 weeks and are characterised by sentinel skin tags, hypertrophied anal papilla, exposed internal sphincter fibres, and elevated resting sphincter pressure. While anal stretch can produce fissure healing, the uncontrolled nature of the procedure means healing rates are achieved at the cost of sphincter damage.

Anal stenosis — a pathological narrowing of the anal canal — arising from prior haemorrhoidectomy, inflammatory bowel disease (particularly Crohn's disease), radiation injury, or scarring from previous anal surgery is a more accepted current indication for graduated anal dilatation. In this context, controlled pneumatic balloon dilatation or digital dilatation with anal dilators performed progressively over weeks to months can restore normal anal calibre and relieve constipation and obstructed defaecation.

Patients with symptomatic anal stenosis causing difficulty with defaecation, pain, and incomplete bowel emptying who have not responded to laxatives, dietary fibre, and regular use of anal dilators are candidates for formal dilatation under anaesthesia. Patients with chronic anal fissure who have failed conservative treatment (topical glyceryl trinitrate, diltiazem cream, botulinum toxin injection) may be considered for surgical sphincter-reducing procedures, though most colorectal surgeons now prefer lateral internal sphincterotomy over anal stretch for fissure.

Contraindications include patients with pre-existing sphincter weakness or faecal incontinence, patients with prior obstetric sphincter trauma (particularly women with previous third or fourth degree perineal tears), patients with inflammatory bowel disease causing active perianal disease, and patients in whom the degree of sphincter hypertonia has not been confirmed by anorectal physiology testing. In these groups, the already compromised sphincter mechanism makes further stretch-induced damage unacceptable.

Classic anal stretch (Lord's procedure) involves four-finger digital dilatation of the anal canal under general or spinal anaesthesia in a day surgery setting. The procedure takes approximately 15 minutes. It has been largely replaced in modern colorectal practice for anal fissure by lateral internal sphincterotomy, which produces a controlled, measured division of the lower third of the internal anal sphincter under direct vision, providing equivalent healing rates with substantially lower incontinence risk.

For anal stenosis, controlled progressive dilatation is performed using Hegar dilators or pneumatic anal dilators of increasing size under anaesthesia, followed by self-dilation with patient-administered anal dilators (such as St Mark's dilators) several times daily for several weeks. This gradual approach minimises the risk of sphincter damage while achieving progressive widening of the narrowed segment. For severe post-haemorrhoidectomy anal stenosis, surgical options including Y-V advancement flap and mucosal advancement flap provide definitive correction without sphincter injury.

Selecting the most appropriate Anal Stretch approach requires a structured assessment of patient-specific factors. The treating specialist evaluates disease severity, prior treatment history, comorbidities, and patient preferences before recommending a specific protocol. Combination approaches are often more effective than monotherapy — integrating pharmacological, procedural, or rehabilitative elements to address multiple disease mechanisms simultaneously. Dose or intensity is titrated incrementally based on clinical response, tolerability, and objective outcome measures. In patients with refractory disease or inadequate response to first-line protocols, escalation to higher-intensity or specialist-delivered treatment options is indicated. Multidisciplinary team (MDT) review ensures that surgical, medical, and allied health perspectives are integrated into the final management plan, particularly for complex or high-risk cases where multiple treatment pathways are viable and the risk-benefit balance requires careful deliberation.

In the context of anal stenosis, controlled dilatation achieves satisfactory widening of the anal canal and relief of constipation and pain in approximately 60–80% of patients, particularly those with mild to moderate stenosis. The procedure is day-case, quick, and requires no incision. For patients who respond, repeated dilations may not be needed if a home dilator programme maintains patency.

For anal fissure, historical data from Lord's original series showed healing rates of approximately 80–90%, but subsequent studies identified significant rates of incontinence — including urgency, flatus incontinence, and faecal soiling — in 0–39% of patients depending on the degree of stretch applied. These figures compare unfavourably with lateral internal sphincterotomy, which achieves healing rates of 92–96% with incontinence rates of 0–5% in appropriately selected patients. The legacy of Lord's procedure remains visible in the historical literature but it is rarely the first-line choice in contemporary colorectal surgery.

The principal and most significant risk of uncontrolled anal dilatation is faecal incontinence, resulting from tearing of the internal and potentially external anal sphincter during stretching. The degree of sphincter damage is unpredictable with manual dilatation and correlates with both the number of fingers used and the force applied. Endoanal ultrasound studies have documented sphincter defects in a high proportion of patients following Lord's procedure, even in those who remain continent. This risk is substantially higher in older patients, women with prior obstetric injury, and those with pre-existing sphincter weakness.

Other complications include bleeding (uncommon, usually minor), infection, delayed healing, and failure to achieve lasting symptom relief requiring further intervention. For anal stenosis dilatation, over-aggressive dilation carries risk of mucosal tear and bleeding. Recurrence of stenosis is common if the home dilator programme is not adhered to. Anaesthetic risks apply as to any surgical procedure under general or spinal anaesthesia.

Anal stretch is performed as a day case procedure; patients are discharged once recovered from anaesthesia, typically within 3–4 hours. Post-operatively, patients may experience mild anal discomfort and minor bleeding with defaecation, which should resolve within 1–2 weeks. High-fibre diet, adequate hydration, and bulk-forming laxatives are prescribed to soften stools and facilitate comfortable defaecation.

For anal stenosis patients, a structured home dilator programme is initiated: patients are taught to insert appropriately sized dilators (lubricated) once or twice daily, gradually increasing size over several weeks. Follow-up at 2–4 weeks assesses progress and any complications. Patients with anal fissure who have undergone surgical treatment require review at 6–8 weeks to confirm healing. Any new or worsening symptoms of incontinence — urgency, soiling, flatus incontinence — must be reported promptly and assessed with anorectal physiology and endoanal ultrasound.

Anal stretch or anal dilatation under anaesthesia is a relatively low-cost day surgery procedure. In the United States, the total cost including anaesthesia, surgical, and facility fees is typically $2,000–6,000 for a private outpatient procedure. In the UK, NHS-funded colorectal surgery is available for eligible patients at no direct cost. Private colorectal surgery in the UK typically costs £1,500–4,000 for a day-case anal procedure.

For international patients, colorectal surgery at accredited hospitals in India costs $300–1,200 for day-case procedures, representing a saving of 75–90% versus US prices. Thailand, Turkey, and Poland offer colorectal surgical services at similarly reduced costs. When travelling abroad for colorectal surgery, patients should ensure they are assessed by a board-certified colorectal surgeon and that anorectal physiology testing has been performed to guide appropriate surgical planning.

Lateral internal sphincterotomy (LIS) is the gold-standard surgical alternative to anal stretch for chronic anal fissure, with superior healing rates and a substantially lower incontinence risk. LIS involves precise division of the lower third of the internal anal sphincter under direct vision, providing controlled sphincter relaxation. It is the procedure of choice for patients with chronic fissure who have failed pharmacological sphincter relaxation.

Botulinum toxin injection into the internal anal sphincter is an effective, reversible, non-surgical alternative for chronic anal fissure, producing temporary sphincter relaxation for 3–4 months. Healing rates are approximately 60–80%, with the advantage of no permanent sphincter damage. Repeated injections are required in non-healers. Topical pharmacological agents — glyceryl trinitrate 0.4% (Rectogesic), diltiazem 2% cream — are first-line conservative treatments that relax the IAS through nitric oxide-mediated mechanisms, achieving healing in 40–60% of patients without any surgical risk.